Total Funding
2
22
Total FundingDebt Financing raised
Growth Score
-3 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
93907
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.
Acquired by 
Boston Scientific
- Michael Hoey: Co-Founder, Chief Technology Officer & Board of DirectorsPast Role: Hamline University, Professor
J. Robert Paulson: President, CEO & DirectorPast Role: Medtronic, Vice President of Corporate Strategy
About the Company
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. BPH afflicts more than 32 million men in the United States.
